Surface-enhanced Raman spectral biomarkers correlate with Ankle Brachial Index and characterize leg muscle biochemical composition of patients with peripheral arterial disease
Open Access
- 17 September 2014
- journal article
- research article
- Published by Wiley in Physiological Reports
- Vol. 2 (9) , e12148
Abstract
Peripheral arterial disease (PAD) is characterized by atherosclerotic blockages of the arteries supplying the lower extremities, which cause a progressive accumulation of ischemic injury to the skeletal muscles of the lower limbs. This injury includes altered metabolic processes, damaged organelles, and compromised bioenergetics in the affected muscles. The objective of this study was to explore the association of Raman spectral signatures of muscle biochemistry with the severity of atherosclerosis in the legs as determined by the Ankle Brachial Index (ABI) and clinical presentation. We collected muscle biopsies from the gastrocnemius (calf muscle) of five patients with clinically diagnosed claudication, five patients with clinically diagnosed critical limb ischemia (CLI), and five control patients who did not have PAD. A partial least squares regression (PLSR) model was able to predict patient ABI with a correlation coefficient of 0.99 during training and a correlation coefficient of 0.85 using a full cross‐validation. When using the first three PLS factor scores in combination with linear discriminant analysis, the discriminant model was able to correctly classify the control, claudicating, and CLI patients with 100% accuracy, using a full cross‐validation procedure. Raman spectroscopy is capable of detecting and measuring unique biochemical signatures of skeletal muscle. These signatures can discriminate control muscles from PAD muscles and correlate with the ABI and clinical presentation of the PAD patient. Raman spectroscopy provides novel spectral biomarkers that may complement existing methods for diagnosis and monitoring treatment of PAD patients.Keywords
Funding Information
- Nebraska Research Initiative grant from the University of Nebraska-Lincoln
- National Institutes of Health (R01AG034995)
- National Science Foundation (CMMI 1126208)
- Charles and Mary Heider Fund for Excellence in Vascular Surgery
- Alexander S. Onassis Public Benefit Foundation
- VA Nebraska-Western Iowa Health Care System
This publication has 55 references indexed in Scilit:
- Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial diseaseJournal of Translational Medicine, 2013
- A validated biomarker panel to identify peripheral artery diseaseVascular Medicine, 2012
- High-Sensitivity C-Reactive Protein and Ankle Brachial Index in a Finnish Cardiovascular Risk PopulationInternational Journal of Angiology, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Vascular Hospitalization Rates and Costs in Patients With Peripheral Artery Disease in the United StatesCirculation: Cardiovascular Quality and Outcomes, 2010
- Multifactorial Determinants of Functional Capacity in Peripheral Arterial DiseaseJACC, 2009
- Method for automated background subtraction from Raman spectra containing known contaminantsThe Analyst, 2009
- One-Year Costs in Patients With a History of or at Risk for Atherothrombosis in the United StatesCirculation: Cardiovascular Quality and Outcomes, 2008
- Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damageAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Metabolic syndrome in peripheral arterial disease: Relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidityJournal of Vascular Surgery, 2006